Strain Data Sheet

RBRC01663

Strain Information

Image
BRC No.RBRC01663
TypeTransgene CongenicCartagena
SpeciesMus musculus
Strain nameB6D2-Tg(KRT14-Ahr-CA)239Mym/MymRbrc
Former Common nameK14-AhR-CA TG mouse line 239, B6D2-Tg(hK14-AhR-CA)239Mym/MymRbrc
H-2 Haplotype
ES Cell line
Background strainJcl:B6D2F1
Appearancebrown [a/a b/b C/C D/D]
dilute black [a/a B/? C/C d/d]
black [a/a B/? C/C D/?]
dilute brown [a/a b/b C/C d/d]
Strain developmentDeveloped by Dr. Masayuki Yamamoto at Tsukuba University in 2002. A cDNA fragment encording the constitutive active form of mouse AhR (AhR-CA) under the human cytokeratin 14 promoter was injected into the pronuclei of fertilized egges of B6D2F1.
Strain descriptionK14-AhR-CA transgenic mice carry a cDNA fragment encording the constitutive active form of mouse AhR (aryl hydrocarbon receptor) under control of human cytokeratin 14 promoter. The aryl hydrocarbon receptor (AhR) (dioxin receptor) is a transcription factor that mediate to catalyze xenobiotic Phase I metabolism. Tg hemizygote mice are normal at birth, but severe skin lesions with itching develop postnatally. This strain is useful for the evaluation of the causal relationship between the AhR gene expression and inflammatory dermatitis.
Colony maintenanceCross to B6D2F1 (Hemizygous x Jcl:B6D2F1)Tg hemizygote mice are normal at birth, but severe skin lesions with itching develop postnatally.
ReferencesMol. Cell. Biol., 25, 9360-9368 (2005). 16227587

Health Report

Examination Date / Room / Rack

Gene

Gene info
Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
Ahraryl-hydrocarbon receptorUNAhrAh, Ahh, Ahre, dioxin receptor, Inhuman Keratin14 promoter

Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
HAhuman influenza virus HA (hemagglutinin) tag sequenceUNHA

Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
poly ApolyAUNpoly A

Ordering Information

Donor DNAhuman keratin 14 genomic DNA, mouse Ahr cDNA, HA (hemagglutinin) tag sequence, poly A
Research applicationDermatology Research
Immunology and Inflammation Research
Specific Term and ConditionsThe RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Mol. Cell. Biol., 25, 9360-9368 (2005).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT agrees to include the DEPOSITOR/DEVELOPER as a co-author in any publications resulted by the use of the BIOLOGICAL RESOURCE during the first 2 years after deposition by the DEPOSITOR to the RIKEN BRC. The RECIPIENT should contact the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE.
DepositorMasayuki Yamamoto (University of Tsukuba)
Strain Statusan icon for Frozen embryosFrozen embryos
Strain AvailabilityRecovered litters from cryopreserved embryos (2 to 4 months)
Cryopreserved embryos (within 1 month)
Additional Info.Mouse of the Month Aug 2007
Necessary documents for ordering:
  1. Approval form (Japanese / English)
  2. Order form (Japanese / English)
  3. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
  4. Acceptance of responsibility for living modified organism (Japanese / English)
Lab HP (Japanese)
Genotyping protocol -PCR-

BRC mice in Publications

No Data